Abstract
The application of stevia glycosides in the food industry has grown steadily in the last two decades. Besides the use of its constituents as natural sweeteners, increasing attention has been given to their potential health benefits and therapeutic applications. Whereas in some cases clinical studies have been realized (prominently, to investigate its hypoglycemic and antihypertensive activity) many of them have failed to cover the expectations from preclinical investigations. Here, we review current knowledge on stevia constituents’ pharmacokinetics (both in rodents and in humans) and some of the most profusely investigated potential medical/health-related applications: i.e. diabetes and metabolic syndrome, hypertension, antimicrobial and anticancer activity. The outcome of available clinical studies and the perspectives of Stevia therapeutic uses are discussed in connection with pharmacokinetics knowledge.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
